Search Results: cancer survivor (77)

After a pediatric cancer diagnosis, chances of infections remain elevated for more than a decade, according to a recent study.

A new Northwestern Medicine trial will test whether a telehealth-based intervention that addresses three behavioral risk factors at once can modify cancer patients’ lifestyles to improve their outcomes.

Harmful side effects from a common chemotherapy drug could be prevented in patients with a specific mutation by targeting retinoic acid receptors, according to a recent study.

A targeted virtual health intervention was effective in reducing fear of recurrence among breast cancer survivors.

A Northwestern Medicine study has found that women with hormone receptor-positive breast cancer were more likely to discontinue hormone therapy early due to poor quality of life-related outcomes.

Trisha Kaundinya, a first-year student in Feinberg’s MD/MPH Program, and Elizabeth Adams, a first-year medical student, are the co-founders and co-presidents of Feinberg’s Disability Advocacy Coalition in Medicine.

A team of Northwestern Medicine investigators led by Rina Fox, PhD, MPH, received a Cancer and Aging Translational Bridge Award to investigate circadian disruption in lymphoma.

Three Feinberg students have received Harvard-BU-Northwestern-University of New Mexico Fogarty Global Health Fellowships, supporting work in Botswana, South Africa and Tanzania.

A specific cell signaling protein may be used to enhance the sensitivity of medulloblastoma tumors to immunotherapy, potentially improving quality of life for patients with the malignant pediatric brain cancer.

In women with early-stage breast cancer, Northwestern Medicine investigators found chemoendocrine therapy was associated with greater cognitive impairment at three and six months compared to endocrine therapy alone.